while waiting for FDA approval of denosumab(RANKL inhibitor vs bone mets,osteoporosis
 

...it turns out that an already approved drug imatinib (Gleevec) approved for leukemia and GIST has a similar effect, at least preclinically in mice--

http://www.oncolink.com/resources/ar...th=01&id=15938